$OBLG
Oblong, Inc.

2023 Q2 Form 10-Q Financial Statement

#000074621023000040 Filed on May 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $956.0K $1.038M $1.532M
YoY Change -28.28% -32.25% -20.13%
Cost Of Revenue $834.0K $762.0K $1.033M
YoY Change -9.94% -26.23% -19.92%
Gross Profit $122.0K $276.0K $499.0K
YoY Change -70.02% -44.69% -20.54%
Gross Profit Margin 12.76% 26.59% 32.57%
Selling, General & Admin $1.519M $1.387M $2.252M
YoY Change 1.13% -38.41% -13.18%
% of Gross Profit 1245.08% 502.54% 451.3%
Research & Development $5.000K $6.000K $1.004M
YoY Change -98.74% -99.4% 45.09%
% of Gross Profit 4.1% 2.17% 201.2%
Depreciation & Amortization $87.00K $86.00K $627.0K
YoY Change -85.48% -86.28% -13.16%
% of Gross Profit 71.31% 31.16% 125.65%
Operating Expenses $5.000K $1.393M $3.256M
YoY Change -99.74% -57.22% -0.91%
Operating Profit -$1.091M -$1.203M -$4.522M
YoY Change -87.92% -73.4% 32.57%
Interest Expense -$6.000K -$5.000K -$6.000K
YoY Change -16.67% -70.0%
% of Operating Profit
Other Income/Expense, Net $42.00K $22.00K -$6.000K
YoY Change -466.67% -72.73%
Pretax Income -$1.049M -$1.181M -$4.528M
YoY Change -88.39% -73.92% 31.9%
Income Tax $0.00 $38.00K $11.00K
% Of Pretax Income
Net Earnings -$1.049M -$1.219M -$4.539M
YoY Change -88.39% -73.14% 32.22%
Net Earnings / Revenue -109.73% -117.44% -296.28%
Basic Earnings Per Share -$0.78 -$0.60 -$0.15
Diluted Earnings Per Share -$0.78 -$0.60 -$0.15
COMMON SHARES
Basic Shares Outstanding 2.580M shares 2.063M shares 30.82M shares
Diluted Shares Outstanding 2.487M shares 2.065M shares 30.82M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.872M $3.714M $6.525M
YoY Change 34.56% -43.08% 63.13%
Cash & Equivalents $6.872M $3.714M $6.586M
Short-Term Investments
Other Short-Term Assets $836.0K $947.0K $1.502M
YoY Change -27.3% -36.95% 25.17%
Inventory $402.0K $634.0K $1.718M
Prepaid Expenses
Receivables $244.0K $392.0K $555.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $8.354M $5.687M $10.30M
YoY Change 6.75% -44.79% 21.97%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $3.000K $122.0K
YoY Change -100.0% -97.54% -71.63%
Goodwill $6.229M
YoY Change -15.45%
Intangibles $432.0K $518.0K $6.982M
YoY Change -93.25% -92.58% -26.84%
Long-Term Investments
YoY Change
Other Assets $22.00K $31.00K $64.00K
YoY Change 0.0% -51.56% -43.36%
Total Long-Term Assets $519.0K $651.0K $13.93M
YoY Change -92.3% -95.33% -23.58%
TOTAL ASSETS
Total Short-Term Assets $8.354M $5.687M $10.30M
Total Long-Term Assets $519.0K $651.0K $13.93M
Total Assets $8.873M $6.338M $24.23M
YoY Change -39.1% -73.84% -9.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $136.0K $207.0K $553.0K
YoY Change -58.15% -62.57% -48.75%
Accrued Expenses $763.0K $1.665M $1.147M
YoY Change -21.82% 45.16% -25.18%
Deferred Revenue $234.0K $341.0K $736.0K
YoY Change -65.89% -53.67% -20.86%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.201M $2.352M $2.831M
YoY Change -49.22% -16.92% -58.1%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $57.00K $84.00K $472.0K
YoY Change -79.72% -82.2% -52.8%
Total Long-Term Liabilities $57.00K $84.00K $472.0K
YoY Change -79.72% -82.2% -52.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.201M $2.352M $2.831M
Total Long-Term Liabilities $57.00K $84.00K $472.0K
Total Liabilities $1.258M $2.436M $3.303M
YoY Change -52.46% -26.25% -57.33%
SHAREHOLDERS EQUITY
Retained Earnings -$226.1M -$225.1M -$206.4M
YoY Change 4.94% 9.02% 5.17%
Common Stock $233.9M $229.1M $227.6M
YoY Change 2.78% 0.7% 5.64%
Preferred Stock
YoY Change
Treasury Stock (at cost) $181.0K $181.0K
YoY Change 0.0% 0.0%
Treasury Stock Shares 113.3K shares
Shareholders Equity $7.615M $3.902M $20.93M
YoY Change
Total Liabilities & Shareholders Equity $8.873M $6.338M $24.23M
YoY Change -39.1% -73.84% -9.16%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$1.049M -$1.219M -$4.539M
YoY Change -88.39% -73.14% 32.22%
Depreciation, Depletion And Amortization $87.00K $86.00K $627.0K
YoY Change -85.48% -86.28% -13.16%
Cash From Operating Activities -$1.338M -$844.0K -$2.404M
YoY Change -11.21% -64.89% 94.66%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $11.00K
YoY Change -100.0% -35.29%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $1.000K
YoY Change -100.0% -100.0%
Cash From Investing Activities $0.00 $0.00 -$10.00K
YoY Change -100.0% -100.0% -41.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.496M $1.473M $0.00
YoY Change
NET CHANGE
Cash From Operating Activities -1.338M -$844.0K -$2.404M
Cash From Investing Activities 0.000 $0.00 -$10.00K
Cash From Financing Activities 4.496M $1.473M $0.00
Net Change In Cash 3.158M $629.0K -$2.414M
YoY Change -313.52% -126.06% 92.81%
FREE CASH FLOW
Cash From Operating Activities -$1.338M -$844.0K -$2.404M
Capital Expenditures $0.00 $0.00 $11.00K
Free Cash Flow -$1.338M -$844.0K -$2.415M
YoY Change -11.21% -65.05% 92.89%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000746210
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.06667
CY2023Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.06667
CY2023Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.06667
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-35376
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
OBLONG, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0312442
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
25587 Conifer Road
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 105-231
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Conifer
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80433
CY2023Q1 dei City Area Code
CityAreaCode
303
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
640-3838
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
OBLG
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2580370 shares
CY2023Q1 us-gaap Cash
Cash
3714000 usd
CY2022Q4 us-gaap Cash
Cash
3085000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
392000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
415000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
634000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
723000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
947000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
649000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
5687000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
4872000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
518000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
604000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
99000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
142000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
31000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
40000 usd
CY2023Q1 us-gaap Assets
Assets
6338000 usd
CY2022Q4 us-gaap Assets
Assets
5661000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
207000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
184000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1665000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1074000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
341000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
436000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
139000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
219000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2352000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1913000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17000 usd
CY2023Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
84000 usd
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
114000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
2436000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2044000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 glow Preferred Stock Stated Value
PreferredStockStatedValue
6550000 usd
CY2023Q1 glow Preferred Stock Stated Value
PreferredStockStatedValue
6550000 usd
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
42000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
42000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
6550 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
6550 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3617000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6338000 usd
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2070861 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2070861 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2063308 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2063308 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
7553 shares
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
7553 shares
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
181000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
181000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
229149000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
227645000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-225066000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-223847000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
3902000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5661000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1038000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1532000 usd
CY2023Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
762000 usd
CY2022Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1033000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
276000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
499000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6000 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1004000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
218000 usd
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
562000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1169000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1690000 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1138000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
86000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
627000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
1479000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
5021000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1203000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4522000 usd
CY2023Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
5000 usd
CY2022Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
6000 usd
CY2023Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
27000 usd
CY2022Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
22000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1181000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4528000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1219000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4539000 usd
CY2023Q1 us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
25000 usd
CY2022Q1 us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
0 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1244000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4539000 usd
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.60
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.60
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.20
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.20
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2065000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2065000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2065000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2065000 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3617000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1219000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
31000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1473000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
3902000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
25497000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4539000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
52000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
84000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
20926000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1219000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4539000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
86000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
627000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-24000 usd
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
111000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
43000 usd
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
127000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
31000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
52000 usd
CY2023Q1 glow Forfeiture Of Unvested Stock Options
ForfeitureOfUnvestedStockOptions
0 usd
CY2022Q1 glow Forfeiture Of Unvested Stock Options
ForfeitureOfUnvestedStockOptions
84000 usd
CY2023Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2022Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1138000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-47000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-183000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-89000 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-103000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
298000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
360000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-9000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-45000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
23000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
294000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
591000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
188000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-125000 usd
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-126000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-97000 usd
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-163000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-844000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2404000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
0 usd
CY2022Q1 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
1000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10000 usd
CY2023Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1473000 usd
CY2022Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1473000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
629000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2414000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3085000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3714000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6586000 usd
CY2023Q1 us-gaap Cash
Cash
3714000 usd
CY2022Q1 us-gaap Cash
Cash
6525000 usd
CY2023Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 usd
CY2022Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
61000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3714000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6586000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
2000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
31000 usd
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023Q1 glow Warrant Modification
WarrantModification
25000 usd
CY2022Q1 glow Warrant Modification
WarrantModification
0 usd
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
172000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
518000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparation of the Condensed Consolidated Financial Statements in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual amounts could differ from the estimates made. We continually evaluate estimates used in the preparation of our consolidated financial statements for reasonableness. Appropriate adjustments, if any, to the estimates used are made prospectively based upon such periodic evaluation. The significant areas of estimation include determining the allowance for doubtful accounts, the estimated lives and recoverability </span></div>of intangible assets, the inputs used in the valuation of intangible assets in connection with our impairment test, and the inputs used in the fair value of equity-based awards.
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3714000 usd
CY2023Q1 glow Working Capital
WorkingCapital
3335000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1219000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-844000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
690000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
690000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
86000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
604000 usd
CY2023Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2023Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
86000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
580000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
260000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
258000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
518000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
0 usd
CY2022Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1138000 usd
CY2022Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
6229000 usd
CY2023Q1 us-gaap Accrued Rent Current
AccruedRentCurrent
151000 usd
CY2022Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
0 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
779000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
707000 usd
CY2023Q1 glow Deposits Current
DepositsCurrent
271000 usd
CY2022Q4 glow Deposits Current
DepositsCurrent
128000 usd
CY2023Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
344000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
57000 usd
CY2023Q1 glow Accrued Sales Taxes And Regulatory Fees
AccruedSalesTaxesAndRegulatoryFees
43000 usd
CY2022Q4 glow Accrued Sales Taxes And Regulatory Fees
AccruedSalesTaxesAndRegulatoryFees
59000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
77000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
123000 usd
CY2023Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1665000 usd
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1074000 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
46000 usd
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
139000 usd
CY2023Q1 us-gaap Sublease Income
SubleaseIncome
16000 usd
CY2022Q1 us-gaap Sublease Income
SubleaseIncome
66000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
99000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
142000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
139000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
219000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
139000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
236000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
100000 usd
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
173000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
125000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
17000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
142000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
139000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
659000 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
728000 usd
CY2022 glow Operating Lease Right Of Use Asset Additions
OperatingLeaseRightOfUseAssetAdditions
11000 usd
CY2022 glow Operating Lease Liability Additions
OperatingLeaseLiabilityAdditions
11000 usd
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
349000 usd
CY2022 glow Operating Lease Liability Amortization And Payments
OperatingLeaseLiabilityAmortizationAndPayments
503000 usd
CY2022 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
179000 usd
CY2022 glow Operating Lease Liability Impairment Charges
OperatingLeaseLiabilityImpairmentCharges
0 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
142000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
236000 usd
CY2023Q1 glow Operating Lease Right Of Use Asset Additions
OperatingLeaseRightOfUseAssetAdditions
0 usd
CY2023Q1 glow Operating Lease Liability Additions
OperatingLeaseLiabilityAdditions
0 usd
CY2023Q1 glow Operating Lease Right Of Use Asset Terminations And Modifications
OperatingLeaseRightOfUseAssetTerminationsAndModifications
0 usd
CY2023Q1 glow Operating Lease Liability Terminations And Modifications
OperatingLeaseLiabilityTerminationsAndModifications
0 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
43000 usd
CY2023Q1 glow Operating Lease Liability Amortization And Payments
OperatingLeaseLiabilityAmortizationAndPayments
97000 usd
CY2023Q1 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0 usd
CY2023Q1 glow Operating Lease Liability Impairment Charges
OperatingLeaseLiabilityImpairmentCharges
0 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
99000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
139000 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2070861 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2063308 shares
CY2020Q4 glow Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
34767 shares
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
61.20
CY2020Q4 glow Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
41667 shares
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
82.35
CY2023Q1 glow Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
4479947 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
343101 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
66.34
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
343101 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
66.34
CY2023Q1 glow Class Of Warrant Or Right Granted
ClassOfWarrantOrRightGranted
4136846 shares
CY2023Q1 glow Class Of Warrant Or Right Granted Weighted Average Exercise Price
ClassOfWarrantOrRightGrantedWeightedAverageExercisePrice
1.71
CY2023Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4479947 shares
CY2023Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
6.66
CY2023Q1 glow Preferred Stock Shares Designated
PreferredStockSharesDesignated
1983250 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
6550 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
6550 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
6501 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
334 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
10000 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
10000 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
48.75
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
16668 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
27169 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
113.63
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
7169 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
0 shares
CY2022 glow Share Based Compensation Arrangements By Share Based Payment Award Options Vested In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice
0
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
3332 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
48.75
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
501 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
410.18
CY2022 glow Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period Number Of Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriodNumberOfShares
501 shares
CY2022 glow Share Based Compensation Arrangement By Share Based Payment Award Options Expired Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredWeightedAverageExercisePrice
410.18
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
143.63
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
10000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
206.85
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
6501 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
289.77
CY2023Q1 glow Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period Number Of Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriodNumberOfShares
6501 shares
CY2023Q1 glow Share Based Compensation Arrangement By Share Based Payment Award Options Expired Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredWeightedAverageExercisePrice
289.77
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10167 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
50.17
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3499 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
52.87
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10167 shares
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y1M13D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
50.17
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3499 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
52.87
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
154000 usd
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1219000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4539000 usd
CY2023Q1 us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
25000 usd
CY2022Q1 us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
0 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1244000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4539000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2065000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2065000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2065000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2065000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.60
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.60
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.20
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.20
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1038000 usd
CY2023Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
762000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
276000 usd
CY2023Q1 glow Gross Profit Percentage
GrossProfitPercentage
0.27
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
1479000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1203000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
22000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1181000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1219000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1532000 usd
CY2022Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1033000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
499000 usd
CY2022Q1 glow Gross Profit Percentage
GrossProfitPercentage
0.33
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
5021000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4522000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4528000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4539000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1038000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1532000 usd

Files In Submission

Name View Source Status
0000746210-23-000040-index-headers.html Edgar Link pending
0000746210-23-000040-index.html Edgar Link pending
0000746210-23-000040.txt Edgar Link pending
0000746210-23-000040-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
glow-20230331.htm Edgar Link pending
glow-20230331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
oblg-ex311_20230331xq1.htm Edgar Link pending
oblg-ex312_20230331xq1.htm Edgar Link pending
oblg-ex321_20230331xq1.htm Edgar Link pending
oblgconformedversionofamen.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
glow-20230331_cal.xml Edgar Link unprocessable
glow-20230331_def.xml Edgar Link unprocessable
glow-20230331_lab.xml Edgar Link unprocessable
glow-20230331_pre.xml Edgar Link unprocessable
glow-20230331_htm.xml Edgar Link completed
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending